Talis Biomedical Corp (TLIS) Financials

$2.84

$1.12 (65.12%)

As on 02-Apr-2026 09:30EDT

Market cap

$5 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	0.30	0.41	3.65	0.00	10.94	3.98
Cost of Revenue	0.98	0.04	8.39	2.62	1.37	--
Gross Profit	-0.68	0.37	-4.74	-2.62	9.56	3.98
Operating Expenses	48.52	67.19	110.40	191.82	100.75	26.70
Operating Profit (EBIT)	-50.20	-66.82	-115.14	-191.82	-91.18	-26.70
Other Income	--	--	--	--	--	--
Profit before Tax	-51.03	-62.01	-113.01	-192.04	-91.13	-27.47
Provision for Tax	1.64	4.91	-2.13	-1.58	-0.05	-0.04
Profit after Tax (Net Income)	-51.03	-62.01	-110.89	-190.46	-91.08	-27.43
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-113.01	-192.04	-91.13	26.38

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	48.63	69.12	126.74	233.98	-108.57	-21.14
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	15.88	16.79	29.88	12.75	290.95	42.84
Current Liabilities	8.20	8.77	12.67	19.11	16.03	4.04
Total Liabilities	80.90	94.67	169.29	265.83	198.41	25.73

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	9.10	20.66	36.01	29.71	9.68	1.63
Current Assets	63.60	77.68	133.28	236.12	188.72	24.11
Total Assets	80.90	94.67	169.29	265.83	198.41	25.73
Total Debt*	18.80	19.67	33.58	13.98	0.69	--
Net Current Assets	55.41	68.91	120.61	217.01	172.70	20.07

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-53.24	-100.14	-171.38	-87.02	-24.33
Cash Flow from Investing Activities	--	-0.49	-1.62	-2.87	-8.20	-0.58
Cash from Financing Activities	--	0.03	0.41	234.43	246.75	39.61
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	-27.00	-29.35	-62.07	-108.18	-52.10	-15.73
Cash EPS ($)	--	-27.40	-57.13	-107.29	-51.66	-15.31
Adjusted Book Value ($)	--	32.72	70.95	132.90	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-25.20	-56.05	-97.35	-49.78	-13.95
Free Cash Flow per Share ($)	--	-25.43	-56.96	-98.98	-54.47	-14.28

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-49.78	-54.32	-271.94	141.18	75.01
ROE (%)	-86.67	-63.32	-61.48	-303.75	140.43	75.01
ROA (%)	-47.86	-46.98	-50.97	-82.05	-81.27	-147.84
EBIT Margin (%)	-18,410.00	-16,217.23	-3,152.77	-2,397,700,000.00	-833.15	-671.34
Net Margin (%)	-17,008.67	-15,050.24	-3,036.28	-2,380,725,000.00	-832.66	-689.77
Cash Profit Margin (%)	-0.02	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	-70.65	-0.89	456,499.00	-1.00	1.75	0.66
EBIT Growth (%)	41.67	41.97	39.97	-110.49	-241.32	-24.59
Net Profit Growth (%)	39.17	44.08	41.78	-109.12	-232.01	-28.57
EPS Growth (%)	42.41	0.53	0.43	-1.08	-2.31	--
Book Value Growth (%)	-49.58	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	-0.25	-0.01	-0.04	--	--
Price / Book Value	0.11	0.23	0.01	0.03	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.86	0.63	0.90	1.11	--	--
Close Price ($)	8.66	7.45	6.69	60.15	--	--
High Price ($)	9.60	9.75	65.10	508.50	--	--
Low Price ($)	4.35	4.35	6.32	54.60	--	--
Market Cap ($ Cr)	5.18	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	0.28	0.26	0.06	-0.01	--
Short term debt to equity ratio	0.12	0.04	0.03	0.01	-0.01	-0.01
Current Ratio	7.76	8.86	10.52	12.36	11.78	5.97
Quick Ratio	7.76	--	--	--	8.86	--
Interest Coverage	-42.76	--	-54.13	-141.25	--	--

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	12.14	8.43	2,287,500.00	4.31	45.41
Asset Turnover	0.00	0.00	0.02	--	0.10	0.21
Receivable days	--	158.69	24.55	14,929,593.75	38.02	174.63
Inventory Days	--	--	--	6,502.87	12,404.68	--
Payable days	--	22,747.95	193.49	698.73	860.22	--
Cash Conversion Cycle	--	--	--	14,935,397.89	11,582.47	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.